Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells

Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells

Abstract Triple-negative breast cancer (TNBC) is a subtype of breast cancer lacking targeted therapy currently. Recent studies imply that protein kinase C may play important roles in TNBC development and could be a specific target. In this study, we evaluated the anti-proliferative activity of PKC i...

Full description

Bibliographic Details
Main Authors:	Wanjun Lin, Jiajun Huang, Zhongwen Yuan, Senling Feng, Ying Xie, Wenzhe Ma
Format:	Article
Language:	English
Published:	Nature Portfolio 2017-05-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-017-02222-0

Similar Items

Knockdown of A-kinase anchor protein 4 inhibits proliferation of triple-negative breast cancer cells and
by: Nirmala Jagadish, et al.
Published: (2020-04-01)

Chelerythrine inhibits HSV-1 infection by suppressing virus binding to the cells
by: Ziwei Hu, et al.
Published: (2023-03-01)

Natural Protein Kinase Inhibitors, Staurosporine, and Chelerythrine Suppress Wheat Blast Disease Caused by <i>Magnaporthe oryzae Triticum</i>
by: Moutoshi Chakraborty, et al.
Published: (2022-06-01)

Gonadotropin-releasing hormone receptor inhibits triple-negative breast cancer proliferation and metastasis
by: Cai-Ping Chen, et al.
Published: (2022-03-01)

Cepharanthine sensitizes triple-negative breast cancer cells to doxorubicin and inhibits cell proliferation
by: ZHANG Yanhao, et al.
Published: (2019-11-01)

Overexpression of β-Arrestins inhibits proliferation and motility in triple negative breast cancer cells
by: Saber Yari Bostanabad, et al.
Published: (2021-01-01)

Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling
by: Pradip Shahi Thakuri, et al.
Published: (2020-01-01)

Chelerythrine Chloride: A Potential Rumen Microbial Urease Inhibitor Screened by Targeting UreG
by: Xiaoyin Zhang, et al.
Published: (2021-07-01)

Inhibition of CXorf56 promotes PARP inhibitor-induced cytotoxicity in triple-negative breast cancer
by: Ying Zhu, et al.
Published: (2023-05-01)

LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer
by: Mengxing Li, et al.
Published: (2021-10-01)

PD-1 Cellular Nanovesicles Carrying Gemcitabine to Inhibit the Proliferation of Triple Negative Breast Cancer Cell
by: Hualian Zha, et al.
Published: (2022-06-01)

Vertical pathway inhibition of receptor tyrosine kinases and BAD with synergistic efficacy in triple negative breast cancer
by: Yan Qin Tan, et al.
Published: (2024-01-01)

Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer
by: Natascha Skov, et al.
Published: (2022-09-01)

Rediscovery of Traditional Plant Medicine: An Underestimated Anticancer Drug of Chelerythrine
by: Nianzhi Chen, et al.
Published: (2022-06-01)

HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer
by: Cristina Maccallini, et al.
Published: (2022-05-01)

Role of BET Inhibitors in Triple Negative Breast Cancers
by: Durga Khandekar, et al.
Published: (2020-03-01)

Chelerythrine chloride from Macleaya cordata induces growth inhibition and apoptosis in human gastric cancer BGC-823 cells
by: Zhengfu Zhang, et al.
Published: (2012-10-01)

Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
by: Dong Wang, et al.
Published: (2017-03-01)

Adenosine Stimulate Proliferation and Migration in Triple Negative Breast Cancer Cells.
by: Miriam Fernandez-Gallardo, et al.
Published: (2016-01-01)

Fisetin-metformin co-loaded in mesoporous silica nanoparticles (MSNs) inhibited triple negative breast cancer proliferation
by: Mohammad Reza Karimzadeh, et al.
Published: (2023-10-01)

Cinobufacini Injection Inhibits the Proliferation of Triple-Negative Breast Cancer Through the Pin1–TAZ Signaling Pathway
by: Lu Kong, et al.
Published: (2022-04-01)

Pseudopterosin Inhibits Proliferation and 3D Invasion in Triple-Negative Breast Cancer by Agonizing Glucocorticoid Receptor Alpha
by: Julia Sperlich, et al.
Published: (2018-08-01)

MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors
by: Daniela Schwarzenbacher, et al.
Published: (2019-02-01)

Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines
by: Aleksandra Simiczyjew, et al.
Published: (2018-09-01)

Cyclin-Dependent Kinase Inhibitors Function as Potential Immune Regulators via Inducing Pyroptosis in Triple Negative Breast Cancer
by: Tao Xu, et al.
Published: (2022-06-01)

Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes.
by: Margarite D Matossian, et al.
Published: (2017-01-01)

Spectrophotometric study of time stability and acid-base characteristics of chelerythrine and dihydrochelerythrine
by: Absolínová Helena, et al.
Published: (2010-06-01)

In Vitro Antifungal Activity of Sanguinarine and Chelerythrine Derivatives against Phytopathogenic Fungi
by: Yan-Ni Ma, et al.
Published: (2012-11-01)

Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro
by: Beynon Abrahams, et al.
Published: (2024-03-01)

Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitors
by: Yara Abdou, et al.
Published: (2022-11-01)

SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers
by: Lu, Z, et al.
Published: (2022)

ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells
by: Bora Lim, et al.
Published: (2021-10-01)

SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers
by: Zhen Lu, et al.
Published: (2022-06-01)

EZH2 inhibitors-mediated epigenetic reactivation of FOSB inhibits triple-negative breast cancer progress
by: Ruishan Zhang, et al.
Published: (2020-05-01)

Ezetimibe inhibits triple-negative breast cancer proliferation and promotes cell cycle arrest by targeting the PDGFR/AKT pathway
by: Qinyu He, et al.
Published: (2023-11-01)

Dandelion extract inhibits triple-negative breast cancer cell proliferation by interfering with glycerophospholipids and unsaturated fatty acids metabolism
by: Shan Wang, et al.
Published: (2022-09-01)

A Conditional Dependency on MELK for the Proliferation of Triple-Negative Breast Cancer Cells
by: Yubao Wang, et al.
Published: (2018-11-01)

SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer
by: Peng Liu, et al.
Published: (2018-08-01)

Inhibition Lysosomal Degradation of Clusterin by Protein Kinase D3 Promotes Triple‐Negative Breast Cancer Tumor Growth
by: Yan Liu, et al.
Published: (2021-02-01)

ABL tyrosine kinase inhibition variable effects on the invasive properties of different triple negative breast cancer cell lines.
by: Clément Chevalier, et al.
Published: (2015-01-01)